17905
document
Dihydroergocryptine in the management of senile psycho-organic syndrome . A double-blind , placebo-controlled , randomized study is described of an assessment of the efficacy and relative safety of the ergot alkaloid , dihydroergocryptine , on 52 patients with mild organic brain syndrome over a period of three months using a series of neurophysiological tests . The results indicated that short-term treatment with the alkaloid improved memory impairment . The side-effects were mild and transient in both the dihydroergocryptine and placebo groups and there were no alterations in blood chemistry .
17906
Intervention_Pharmacological
Dihydroergocryptine
17907
Intervention_Control
placebo-controlled
17908
Intervention_Pharmacological
dihydroergocryptine
17909
Intervention_Pharmacological
dihydroergocryptine
17910
Outcome_Other
efficacy and relative safety
17911
Outcome_Mental
neurophysiological tests
17912
Outcome_Mental
memory impairment
17913
Outcome_Adverse-effects
side-effects
17914
Outcome_Physical
alterations in blood chemistry
17915
Participant_Condition
senile psycho-organic syndrome .
17916
Participant_Sample-size
52
17917
Participant_Condition
mild organic brain syndrome